Last reviewed · How we verify
Placebo for FG-M108 — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo for FG-M108 (Placebo for FG-M108) — FutureGen Biopharmaceutical (Beijing) Co., Ltd. This is a placebo, meaning it has no active therapeutic effect.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo for FG-M108 TARGET | Placebo for FG-M108 | FutureGen Biopharmaceutical (Beijing) Co., Ltd | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo for FG-M108 CI watch — RSS
- Placebo for FG-M108 CI watch — Atom
- Placebo for FG-M108 CI watch — JSON
- Placebo for FG-M108 alone — RSS
Cite this brief
Drug Landscape (2026). Placebo for FG-M108 — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-for-fg-m108. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab